nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Niacin—atherosclerosis	0.107	0.169	CbGbCtD
Bisoprolol—CYP2D6—Simvastatin—atherosclerosis	0.0847	0.134	CbGbCtD
Bisoprolol—CYP2D6—Lovastatin—atherosclerosis	0.0829	0.131	CbGbCtD
Bisoprolol—CYP2D6—Pravastatin—atherosclerosis	0.0829	0.131	CbGbCtD
Bisoprolol—CYP3A4—Ezetimibe—atherosclerosis	0.0579	0.0916	CbGbCtD
Bisoprolol—CYP3A4—Rosuvastatin—atherosclerosis	0.0579	0.0916	CbGbCtD
Bisoprolol—CYP3A4—Simvastatin—atherosclerosis	0.0538	0.0851	CbGbCtD
Bisoprolol—CYP3A4—Pravastatin—atherosclerosis	0.0527	0.0833	CbGbCtD
Bisoprolol—CYP3A4—Lovastatin—atherosclerosis	0.0527	0.0833	CbGbCtD
Bisoprolol—Hepatitis—Niacin—atherosclerosis	0.00079	0.00241	CcSEcCtD
Bisoprolol—Hypoaesthesia—Niacin—atherosclerosis	0.000786	0.0024	CcSEcCtD
Bisoprolol—Erythema—Ezetimibe—atherosclerosis	0.000785	0.0024	CcSEcCtD
Bisoprolol—Dysgeusia—Lovastatin—atherosclerosis	0.000784	0.00239	CcSEcCtD
Bisoprolol—Rhinitis—Pravastatin—atherosclerosis	0.00078	0.00238	CcSEcCtD
Bisoprolol—Oedema peripheral—Niacin—atherosclerosis	0.000778	0.00237	CcSEcCtD
Bisoprolol—Hepatitis—Pravastatin—atherosclerosis	0.000778	0.00237	CcSEcCtD
Bisoprolol—Confusional state—Rosuvastatin—atherosclerosis	0.000777	0.00237	CcSEcCtD
Bisoprolol—Back pain—Lovastatin—atherosclerosis	0.000774	0.00236	CcSEcCtD
Bisoprolol—Hypoaesthesia—Pravastatin—atherosclerosis	0.000774	0.00236	CcSEcCtD
Bisoprolol—Pharyngitis—Pravastatin—atherosclerosis	0.000772	0.00236	CcSEcCtD
Bisoprolol—Muscle spasms—Lovastatin—atherosclerosis	0.00077	0.00235	CcSEcCtD
Bisoprolol—Infection—Rosuvastatin—atherosclerosis	0.000766	0.00234	CcSEcCtD
Bisoprolol—Visual impairment—Niacin—atherosclerosis	0.000761	0.00232	CcSEcCtD
Bisoprolol—Alopecia—Simvastatin—atherosclerosis	0.00076	0.00232	CcSEcCtD
Bisoprolol—Back pain—Ezetimibe—atherosclerosis	0.00076	0.00232	CcSEcCtD
Bisoprolol—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000756	0.00231	CcSEcCtD
Bisoprolol—Muscle spasms—Ezetimibe—atherosclerosis	0.000755	0.0023	CcSEcCtD
Bisoprolol—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000755	0.0023	CcSEcCtD
Bisoprolol—Mental disorder—Simvastatin—atherosclerosis	0.000754	0.0023	CcSEcCtD
Bisoprolol—Tremor—Lovastatin—atherosclerosis	0.00075	0.00229	CcSEcCtD
Bisoprolol—Visual impairment—Pravastatin—atherosclerosis	0.00075	0.00229	CcSEcCtD
Bisoprolol—Erythema—Simvastatin—atherosclerosis	0.000749	0.00228	CcSEcCtD
Bisoprolol—Ill-defined disorder—Lovastatin—atherosclerosis	0.000743	0.00227	CcSEcCtD
Bisoprolol—Eye disorder—Niacin—atherosclerosis	0.000738	0.00225	CcSEcCtD
Bisoprolol—Tinnitus—Niacin—atherosclerosis	0.000737	0.00225	CcSEcCtD
Bisoprolol—Dysgeusia—Simvastatin—atherosclerosis	0.000733	0.00224	CcSEcCtD
Bisoprolol—Flushing—Niacin—atherosclerosis	0.000733	0.00224	CcSEcCtD
Bisoprolol—Angioedema—Lovastatin—atherosclerosis	0.000732	0.00223	CcSEcCtD
Bisoprolol—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000729	0.00222	CcSEcCtD
Bisoprolol—Tinnitus—Pravastatin—atherosclerosis	0.000725	0.00221	CcSEcCtD
Bisoprolol—Malaise—Lovastatin—atherosclerosis	0.000722	0.0022	CcSEcCtD
Bisoprolol—Cardiac disorder—Pravastatin—atherosclerosis	0.000722	0.0022	CcSEcCtD
Bisoprolol—Flushing—Pravastatin—atherosclerosis	0.000722	0.0022	CcSEcCtD
Bisoprolol—Muscle spasms—Simvastatin—atherosclerosis	0.00072	0.0022	CcSEcCtD
Bisoprolol—Vertigo—Lovastatin—atherosclerosis	0.000719	0.00219	CcSEcCtD
Bisoprolol—Angioedema—Ezetimibe—atherosclerosis	0.000718	0.00219	CcSEcCtD
Bisoprolol—Angiopathy—Niacin—atherosclerosis	0.000717	0.00219	CcSEcCtD
Bisoprolol—Malaise—Ezetimibe—atherosclerosis	0.000708	0.00216	CcSEcCtD
Bisoprolol—Arrhythmia—Niacin—atherosclerosis	0.000706	0.00215	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000702	0.00214	CcSEcCtD
Bisoprolol—Tremor—Simvastatin—atherosclerosis	0.000702	0.00214	CcSEcCtD
Bisoprolol—Alopecia—Niacin—atherosclerosis	0.000698	0.00213	CcSEcCtD
Bisoprolol—Insomnia—Rosuvastatin—atherosclerosis	0.000697	0.00213	CcSEcCtD
Bisoprolol—Ill-defined disorder—Simvastatin—atherosclerosis	0.000695	0.00212	CcSEcCtD
Bisoprolol—Arrhythmia—Pravastatin—atherosclerosis	0.000695	0.00212	CcSEcCtD
Bisoprolol—Palpitations—Ezetimibe—atherosclerosis	0.000694	0.00212	CcSEcCtD
Bisoprolol—Paraesthesia—Rosuvastatin—atherosclerosis	0.000692	0.00211	CcSEcCtD
Bisoprolol—Erythema—Niacin—atherosclerosis	0.000688	0.0021	CcSEcCtD
Bisoprolol—Alopecia—Pravastatin—atherosclerosis	0.000687	0.0021	CcSEcCtD
Bisoprolol—Cough—Ezetimibe—atherosclerosis	0.000685	0.00209	CcSEcCtD
Bisoprolol—Angioedema—Simvastatin—atherosclerosis	0.000684	0.00209	CcSEcCtD
Bisoprolol—Myalgia—Lovastatin—atherosclerosis	0.000682	0.00208	CcSEcCtD
Bisoprolol—Chest pain—Lovastatin—atherosclerosis	0.000682	0.00208	CcSEcCtD
Bisoprolol—Arthralgia—Lovastatin—atherosclerosis	0.000682	0.00208	CcSEcCtD
Bisoprolol—Anxiety—Lovastatin—atherosclerosis	0.000679	0.00207	CcSEcCtD
Bisoprolol—Dyspepsia—Rosuvastatin—atherosclerosis	0.000679	0.00207	CcSEcCtD
Bisoprolol—Malaise—Simvastatin—atherosclerosis	0.000675	0.00206	CcSEcCtD
Bisoprolol—Discomfort—Lovastatin—atherosclerosis	0.000673	0.00205	CcSEcCtD
Bisoprolol—Vertigo—Simvastatin—atherosclerosis	0.000673	0.00205	CcSEcCtD
Bisoprolol—Myalgia—Ezetimibe—atherosclerosis	0.000669	0.00204	CcSEcCtD
Bisoprolol—Chest pain—Ezetimibe—atherosclerosis	0.000669	0.00204	CcSEcCtD
Bisoprolol—Arthralgia—Ezetimibe—atherosclerosis	0.000669	0.00204	CcSEcCtD
Bisoprolol—Dry mouth—Lovastatin—atherosclerosis	0.000667	0.00203	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000664	0.00203	CcSEcCtD
Bisoprolol—Dysgeusia—Pravastatin—atherosclerosis	0.000663	0.00202	CcSEcCtD
Bisoprolol—Muscle spasms—Niacin—atherosclerosis	0.000661	0.00202	CcSEcCtD
Bisoprolol—Discomfort—Ezetimibe—atherosclerosis	0.000661	0.00202	CcSEcCtD
Bisoprolol—Constipation—Rosuvastatin—atherosclerosis	0.000659	0.00201	CcSEcCtD
Bisoprolol—Pain—Rosuvastatin—atherosclerosis	0.000659	0.00201	CcSEcCtD
Bisoprolol—Confusional state—Lovastatin—atherosclerosis	0.000659	0.00201	CcSEcCtD
Bisoprolol—Dry mouth—Ezetimibe—atherosclerosis	0.000654	0.00199	CcSEcCtD
Bisoprolol—Muscle spasms—Pravastatin—atherosclerosis	0.000651	0.00199	CcSEcCtD
Bisoprolol—Infection—Lovastatin—atherosclerosis	0.000649	0.00198	CcSEcCtD
Bisoprolol—Confusional state—Ezetimibe—atherosclerosis	0.000646	0.00197	CcSEcCtD
Bisoprolol—Thrombocytopenia—Lovastatin—atherosclerosis	0.00064	0.00195	CcSEcCtD
Bisoprolol—Chest pain—Simvastatin—atherosclerosis	0.000638	0.00195	CcSEcCtD
Bisoprolol—Myalgia—Simvastatin—atherosclerosis	0.000638	0.00195	CcSEcCtD
Bisoprolol—Arthralgia—Simvastatin—atherosclerosis	0.000638	0.00195	CcSEcCtD
Bisoprolol—Infection—Ezetimibe—atherosclerosis	0.000637	0.00194	CcSEcCtD
Bisoprolol—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000635	0.00194	CcSEcCtD
Bisoprolol—Anxiety—Simvastatin—atherosclerosis	0.000635	0.00194	CcSEcCtD
Bisoprolol—Tremor—Pravastatin—atherosclerosis	0.000634	0.00194	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000631	0.00192	CcSEcCtD
Bisoprolol—Discomfort—Simvastatin—atherosclerosis	0.00063	0.00192	CcSEcCtD
Bisoprolol—Nervous system disorder—Ezetimibe—atherosclerosis	0.000629	0.00192	CcSEcCtD
Bisoprolol—Angioedema—Niacin—atherosclerosis	0.000628	0.00192	CcSEcCtD
Bisoprolol—Ill-defined disorder—Pravastatin—atherosclerosis	0.000628	0.00192	CcSEcCtD
Bisoprolol—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000628	0.00191	CcSEcCtD
Bisoprolol—Skin disorder—Ezetimibe—atherosclerosis	0.000623	0.0019	CcSEcCtD
Bisoprolol—Angioedema—Pravastatin—atherosclerosis	0.000619	0.00189	CcSEcCtD
Bisoprolol—Vertigo—Niacin—atherosclerosis	0.000618	0.00188	CcSEcCtD
Bisoprolol—Syncope—Niacin—atherosclerosis	0.000617	0.00188	CcSEcCtD
Bisoprolol—Confusional state—Simvastatin—atherosclerosis	0.000616	0.00188	CcSEcCtD
Bisoprolol—Urticaria—Rosuvastatin—atherosclerosis	0.000613	0.00187	CcSEcCtD
Bisoprolol—Oedema—Simvastatin—atherosclerosis	0.000611	0.00186	CcSEcCtD
Bisoprolol—Malaise—Pravastatin—atherosclerosis	0.000611	0.00186	CcSEcCtD
Bisoprolol—Abdominal pain—Rosuvastatin—atherosclerosis	0.00061	0.00186	CcSEcCtD
Bisoprolol—Vertigo—Pravastatin—atherosclerosis	0.000608	0.00186	CcSEcCtD
Bisoprolol—Palpitations—Niacin—atherosclerosis	0.000608	0.00185	CcSEcCtD
Bisoprolol—Infection—Simvastatin—atherosclerosis	0.000607	0.00185	CcSEcCtD
Bisoprolol—Loss of consciousness—Niacin—atherosclerosis	0.000604	0.00184	CcSEcCtD
Bisoprolol—Cough—Niacin—atherosclerosis	0.0006	0.00183	CcSEcCtD
Bisoprolol—Thrombocytopenia—Simvastatin—atherosclerosis	0.000598	0.00183	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000595	0.00182	CcSEcCtD
Bisoprolol—Insomnia—Lovastatin—atherosclerosis	0.000591	0.0018	CcSEcCtD
Bisoprolol—Cough—Pravastatin—atherosclerosis	0.000591	0.0018	CcSEcCtD
Bisoprolol—Paraesthesia—Lovastatin—atherosclerosis	0.000587	0.00179	CcSEcCtD
Bisoprolol—Myalgia—Niacin—atherosclerosis	0.000585	0.00179	CcSEcCtD
Bisoprolol—Arthralgia—Niacin—atherosclerosis	0.000585	0.00179	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000584	0.00178	CcSEcCtD
Bisoprolol—Dyspnoea—Lovastatin—atherosclerosis	0.000583	0.00178	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000581	0.00177	CcSEcCtD
Bisoprolol—Insomnia—Ezetimibe—atherosclerosis	0.00058	0.00177	CcSEcCtD
Bisoprolol—Chest pain—Pravastatin—atherosclerosis	0.000576	0.00176	CcSEcCtD
Bisoprolol—Arthralgia—Pravastatin—atherosclerosis	0.000576	0.00176	CcSEcCtD
Bisoprolol—Myalgia—Pravastatin—atherosclerosis	0.000576	0.00176	CcSEcCtD
Bisoprolol—Paraesthesia—Ezetimibe—atherosclerosis	0.000576	0.00176	CcSEcCtD
Bisoprolol—Dyspepsia—Lovastatin—atherosclerosis	0.000575	0.00175	CcSEcCtD
Bisoprolol—Anxiety—Pravastatin—atherosclerosis	0.000574	0.00175	CcSEcCtD
Bisoprolol—Dry mouth—Niacin—atherosclerosis	0.000573	0.00175	CcSEcCtD
Bisoprolol—Dyspnoea—Ezetimibe—atherosclerosis	0.000571	0.00174	CcSEcCtD
Bisoprolol—Discomfort—Pravastatin—atherosclerosis	0.00057	0.00174	CcSEcCtD
Bisoprolol—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000568	0.00173	CcSEcCtD
Bisoprolol—Dyspepsia—Ezetimibe—atherosclerosis	0.000564	0.00172	CcSEcCtD
Bisoprolol—Fatigue—Lovastatin—atherosclerosis	0.000563	0.00172	CcSEcCtD
Bisoprolol—Oedema—Niacin—atherosclerosis	0.000561	0.00171	CcSEcCtD
Bisoprolol—Pain—Lovastatin—atherosclerosis	0.000559	0.0017	CcSEcCtD
Bisoprolol—Constipation—Lovastatin—atherosclerosis	0.000559	0.0017	CcSEcCtD
Bisoprolol—Confusional state—Pravastatin—atherosclerosis	0.000557	0.0017	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000557	0.0017	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000553	0.00169	CcSEcCtD
Bisoprolol—Asthenia—Rosuvastatin—atherosclerosis	0.000553	0.00169	CcSEcCtD
Bisoprolol—Insomnia—Simvastatin—atherosclerosis	0.000553	0.00169	CcSEcCtD
Bisoprolol—Oedema—Pravastatin—atherosclerosis	0.000553	0.00169	CcSEcCtD
Bisoprolol—Fatigue—Ezetimibe—atherosclerosis	0.000553	0.00169	CcSEcCtD
Bisoprolol—Shock—Niacin—atherosclerosis	0.000552	0.00168	CcSEcCtD
Bisoprolol—Infection—Pravastatin—atherosclerosis	0.000549	0.00167	CcSEcCtD
Bisoprolol—Paraesthesia—Simvastatin—atherosclerosis	0.000549	0.00167	CcSEcCtD
Bisoprolol—Pain—Ezetimibe—atherosclerosis	0.000548	0.00167	CcSEcCtD
Bisoprolol—Constipation—Ezetimibe—atherosclerosis	0.000548	0.00167	CcSEcCtD
Bisoprolol—Tachycardia—Niacin—atherosclerosis	0.000548	0.00167	CcSEcCtD
Bisoprolol—Pruritus—Rosuvastatin—atherosclerosis	0.000546	0.00166	CcSEcCtD
Bisoprolol—Skin disorder—Niacin—atherosclerosis	0.000545	0.00166	CcSEcCtD
Bisoprolol—Dyspnoea—Simvastatin—atherosclerosis	0.000545	0.00166	CcSEcCtD
Bisoprolol—Hyperhidrosis—Niacin—atherosclerosis	0.000543	0.00166	CcSEcCtD
Bisoprolol—Thrombocytopenia—Pravastatin—atherosclerosis	0.000541	0.00165	CcSEcCtD
Bisoprolol—Feeling abnormal—Lovastatin—atherosclerosis	0.000538	0.00164	CcSEcCtD
Bisoprolol—Dyspepsia—Simvastatin—atherosclerosis	0.000538	0.00164	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000534	0.00163	CcSEcCtD
Bisoprolol—Hyperhidrosis—Pravastatin—atherosclerosis	0.000534	0.00163	CcSEcCtD
Bisoprolol—Feeling abnormal—Ezetimibe—atherosclerosis	0.000528	0.00161	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000528	0.00161	CcSEcCtD
Bisoprolol—Diarrhoea—Rosuvastatin—atherosclerosis	0.000528	0.00161	CcSEcCtD
Bisoprolol—Fatigue—Simvastatin—atherosclerosis	0.000527	0.00161	CcSEcCtD
Bisoprolol—Hypotension—Niacin—atherosclerosis	0.000524	0.0016	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000524	0.0016	CcSEcCtD
Bisoprolol—Pain—Simvastatin—atherosclerosis	0.000523	0.00159	CcSEcCtD
Bisoprolol—Constipation—Simvastatin—atherosclerosis	0.000523	0.00159	CcSEcCtD
Bisoprolol—Urticaria—Lovastatin—atherosclerosis	0.000519	0.00158	CcSEcCtD
Bisoprolol—Abdominal pain—Lovastatin—atherosclerosis	0.000517	0.00158	CcSEcCtD
Bisoprolol—Body temperature increased—Lovastatin—atherosclerosis	0.000517	0.00158	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000511	0.00156	CcSEcCtD
Bisoprolol—Dizziness—Rosuvastatin—atherosclerosis	0.00051	0.00156	CcSEcCtD
Bisoprolol—Urticaria—Ezetimibe—atherosclerosis	0.000509	0.00155	CcSEcCtD
Bisoprolol—Insomnia—Niacin—atherosclerosis	0.000508	0.00155	CcSEcCtD
Bisoprolol—Abdominal pain—Ezetimibe—atherosclerosis	0.000507	0.00155	CcSEcCtD
Bisoprolol—Body temperature increased—Ezetimibe—atherosclerosis	0.000507	0.00155	CcSEcCtD
Bisoprolol—Paraesthesia—Niacin—atherosclerosis	0.000504	0.00154	CcSEcCtD
Bisoprolol—Feeling abnormal—Simvastatin—atherosclerosis	0.000504	0.00154	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000503	0.00154	CcSEcCtD
Bisoprolol—Dyspnoea—Niacin—atherosclerosis	0.0005	0.00153	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0005	0.00152	CcSEcCtD
Bisoprolol—Insomnia—Pravastatin—atherosclerosis	0.0005	0.00152	CcSEcCtD
Bisoprolol—Somnolence—Niacin—atherosclerosis	0.000499	0.00152	CcSEcCtD
Bisoprolol—Paraesthesia—Pravastatin—atherosclerosis	0.000496	0.00151	CcSEcCtD
Bisoprolol—Dyspepsia—Niacin—atherosclerosis	0.000494	0.00151	CcSEcCtD
Bisoprolol—Dyspnoea—Pravastatin—atherosclerosis	0.000493	0.0015	CcSEcCtD
Bisoprolol—Dyspepsia—Pravastatin—atherosclerosis	0.000486	0.00148	CcSEcCtD
Bisoprolol—Rash—Rosuvastatin—atherosclerosis	0.000486	0.00148	CcSEcCtD
Bisoprolol—Dermatitis—Rosuvastatin—atherosclerosis	0.000486	0.00148	CcSEcCtD
Bisoprolol—Urticaria—Simvastatin—atherosclerosis	0.000486	0.00148	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Niacin—atherosclerosis	0.000485	0.00148	CcSEcCtD
Bisoprolol—Abdominal pain—Simvastatin—atherosclerosis	0.000483	0.00147	CcSEcCtD
Bisoprolol—Body temperature increased—Simvastatin—atherosclerosis	0.000483	0.00147	CcSEcCtD
Bisoprolol—Headache—Rosuvastatin—atherosclerosis	0.000483	0.00147	CcSEcCtD
Bisoprolol—Hypersensitivity—Lovastatin—atherosclerosis	0.000481	0.00147	CcSEcCtD
Bisoprolol—Pain—Niacin—atherosclerosis	0.00048	0.00146	CcSEcCtD
Bisoprolol—Fatigue—Pravastatin—atherosclerosis	0.000476	0.00145	CcSEcCtD
Bisoprolol—Constipation—Pravastatin—atherosclerosis	0.000473	0.00144	CcSEcCtD
Bisoprolol—Pain—Pravastatin—atherosclerosis	0.000473	0.00144	CcSEcCtD
Bisoprolol—Hypersensitivity—Ezetimibe—atherosclerosis	0.000472	0.00144	CcSEcCtD
Bisoprolol—Asthenia—Lovastatin—atherosclerosis	0.000469	0.00143	CcSEcCtD
Bisoprolol—Pruritus—Lovastatin—atherosclerosis	0.000462	0.00141	CcSEcCtD
Bisoprolol—Asthenia—Ezetimibe—atherosclerosis	0.00046	0.0014	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Niacin—atherosclerosis	0.000459	0.0014	CcSEcCtD
Bisoprolol—Nausea—Rosuvastatin—atherosclerosis	0.000458	0.0014	CcSEcCtD
Bisoprolol—Feeling abnormal—Pravastatin—atherosclerosis	0.000455	0.00139	CcSEcCtD
Bisoprolol—Pruritus—Ezetimibe—atherosclerosis	0.000453	0.00138	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000452	0.00138	CcSEcCtD
Bisoprolol—Hypersensitivity—Simvastatin—atherosclerosis	0.00045	0.00137	CcSEcCtD
Bisoprolol—Diarrhoea—Lovastatin—atherosclerosis	0.000447	0.00136	CcSEcCtD
Bisoprolol—Urticaria—Niacin—atherosclerosis	0.000446	0.00136	CcSEcCtD
Bisoprolol—Abdominal pain—Niacin—atherosclerosis	0.000444	0.00135	CcSEcCtD
Bisoprolol—Body temperature increased—Niacin—atherosclerosis	0.000444	0.00135	CcSEcCtD
Bisoprolol—Urticaria—Pravastatin—atherosclerosis	0.000439	0.00134	CcSEcCtD
Bisoprolol—Asthenia—Simvastatin—atherosclerosis	0.000439	0.00134	CcSEcCtD
Bisoprolol—Diarrhoea—Ezetimibe—atherosclerosis	0.000439	0.00134	CcSEcCtD
Bisoprolol—Abdominal pain—Pravastatin—atherosclerosis	0.000437	0.00133	CcSEcCtD
Bisoprolol—Body temperature increased—Pravastatin—atherosclerosis	0.000437	0.00133	CcSEcCtD
Bisoprolol—Pruritus—Simvastatin—atherosclerosis	0.000432	0.00132	CcSEcCtD
Bisoprolol—Dizziness—Lovastatin—atherosclerosis	0.000432	0.00132	CcSEcCtD
Bisoprolol—Dizziness—Ezetimibe—atherosclerosis	0.000424	0.00129	CcSEcCtD
Bisoprolol—Diarrhoea—Simvastatin—atherosclerosis	0.000418	0.00128	CcSEcCtD
Bisoprolol—Vomiting—Lovastatin—atherosclerosis	0.000415	0.00127	CcSEcCtD
Bisoprolol—Hypersensitivity—Niacin—atherosclerosis	0.000413	0.00126	CcSEcCtD
Bisoprolol—Rash—Lovastatin—atherosclerosis	0.000412	0.00126	CcSEcCtD
Bisoprolol—Dermatitis—Lovastatin—atherosclerosis	0.000412	0.00126	CcSEcCtD
Bisoprolol—Headache—Lovastatin—atherosclerosis	0.000409	0.00125	CcSEcCtD
Bisoprolol—Vomiting—Ezetimibe—atherosclerosis	0.000408	0.00124	CcSEcCtD
Bisoprolol—Hypersensitivity—Pravastatin—atherosclerosis	0.000407	0.00124	CcSEcCtD
Bisoprolol—Dizziness—Simvastatin—atherosclerosis	0.000404	0.00123	CcSEcCtD
Bisoprolol—Rash—Ezetimibe—atherosclerosis	0.000404	0.00123	CcSEcCtD
Bisoprolol—Dermatitis—Ezetimibe—atherosclerosis	0.000404	0.00123	CcSEcCtD
Bisoprolol—Asthenia—Niacin—atherosclerosis	0.000403	0.00123	CcSEcCtD
Bisoprolol—Headache—Ezetimibe—atherosclerosis	0.000402	0.00123	CcSEcCtD
Bisoprolol—Pruritus—Niacin—atherosclerosis	0.000397	0.00121	CcSEcCtD
Bisoprolol—Asthenia—Pravastatin—atherosclerosis	0.000396	0.00121	CcSEcCtD
Bisoprolol—Pruritus—Pravastatin—atherosclerosis	0.000391	0.00119	CcSEcCtD
Bisoprolol—Vomiting—Simvastatin—atherosclerosis	0.000389	0.00119	CcSEcCtD
Bisoprolol—Nausea—Lovastatin—atherosclerosis	0.000388	0.00118	CcSEcCtD
Bisoprolol—Rash—Simvastatin—atherosclerosis	0.000385	0.00118	CcSEcCtD
Bisoprolol—Dermatitis—Simvastatin—atherosclerosis	0.000385	0.00117	CcSEcCtD
Bisoprolol—Diarrhoea—Niacin—atherosclerosis	0.000384	0.00117	CcSEcCtD
Bisoprolol—Headache—Simvastatin—atherosclerosis	0.000383	0.00117	CcSEcCtD
Bisoprolol—Nausea—Ezetimibe—atherosclerosis	0.000381	0.00116	CcSEcCtD
Bisoprolol—Diarrhoea—Pravastatin—atherosclerosis	0.000378	0.00115	CcSEcCtD
Bisoprolol—Dizziness—Niacin—atherosclerosis	0.000371	0.00113	CcSEcCtD
Bisoprolol—Dizziness—Pravastatin—atherosclerosis	0.000365	0.00111	CcSEcCtD
Bisoprolol—Nausea—Simvastatin—atherosclerosis	0.000363	0.00111	CcSEcCtD
Bisoprolol—Vomiting—Niacin—atherosclerosis	0.000357	0.00109	CcSEcCtD
Bisoprolol—Rash—Niacin—atherosclerosis	0.000354	0.00108	CcSEcCtD
Bisoprolol—Dermatitis—Niacin—atherosclerosis	0.000354	0.00108	CcSEcCtD
Bisoprolol—Headache—Niacin—atherosclerosis	0.000352	0.00107	CcSEcCtD
Bisoprolol—Vomiting—Pravastatin—atherosclerosis	0.000351	0.00107	CcSEcCtD
Bisoprolol—Rash—Pravastatin—atherosclerosis	0.000348	0.00106	CcSEcCtD
Bisoprolol—Dermatitis—Pravastatin—atherosclerosis	0.000348	0.00106	CcSEcCtD
Bisoprolol—Headache—Pravastatin—atherosclerosis	0.000346	0.00106	CcSEcCtD
Bisoprolol—Nausea—Niacin—atherosclerosis	0.000333	0.00102	CcSEcCtD
Bisoprolol—Nausea—Pravastatin—atherosclerosis	0.000328	0.001	CcSEcCtD
Bisoprolol—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	3.97e-05	0.001	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AGTR1—atherosclerosis	3.96e-05	0.001	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL4—atherosclerosis	3.96e-05	0.000999	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	3.93e-05	0.000993	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	3.9e-05	0.000984	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	3.87e-05	0.000978	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOA2—atherosclerosis	3.78e-05	0.000954	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOA2—atherosclerosis	3.7e-05	0.000933	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—KNG1—atherosclerosis	3.62e-05	0.000913	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—UTS2—atherosclerosis	3.61e-05	0.00091	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AGTR1—atherosclerosis	3.6e-05	0.000908	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	3.54e-05	0.000893	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—UTS2—atherosclerosis	3.53e-05	0.00089	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCG8—atherosclerosis	3.53e-05	0.00089	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LTA4H—atherosclerosis	3.53e-05	0.00089	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	3.52e-05	0.000888	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CX3CR1—atherosclerosis	3.46e-05	0.000872	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CASR—atherosclerosis	3.46e-05	0.000872	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CX3CL1—atherosclerosis	3.39e-05	0.000855	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	3.38e-05	0.000853	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CASR—atherosclerosis	3.38e-05	0.000853	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—EDN1—atherosclerosis	3.36e-05	0.000847	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CCL5—atherosclerosis	3.33e-05	0.000841	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	3.32e-05	0.000837	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	3.28e-05	0.000829	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	3.26e-05	0.000823	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CNR2—atherosclerosis	3.21e-05	0.000811	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—CXCL8—atherosclerosis	3.21e-05	0.00081	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MMP3—atherosclerosis	3.21e-05	0.000809	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PRKCG—atherosclerosis	3.17e-05	0.000799	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CNR2—atherosclerosis	3.14e-05	0.000793	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	3.14e-05	0.000793	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	3.14e-05	0.000791	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	3.1e-05	0.000782	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—EDN1—atherosclerosis	3.05e-05	0.00077	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCL5—atherosclerosis	3.03e-05	0.000764	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	2.98e-05	0.000753	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	2.96e-05	0.000747	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PRKCG—atherosclerosis	2.88e-05	0.000726	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VWF—atherosclerosis	2.86e-05	0.000723	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOC3—atherosclerosis	2.85e-05	0.000718	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LDLR—atherosclerosis	2.83e-05	0.000714	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	2.83e-05	0.000714	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	2.81e-05	0.00071	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VWF—atherosclerosis	2.8e-05	0.000707	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AGT—atherosclerosis	2.79e-05	0.000703	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCG1—atherosclerosis	2.79e-05	0.000703	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOC3—atherosclerosis	2.78e-05	0.000703	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LDLR—atherosclerosis	2.77e-05	0.000698	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL3—atherosclerosis	2.76e-05	0.000697	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	2.73e-05	0.000688	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL3—atherosclerosis	2.7e-05	0.000682	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLTP—atherosclerosis	2.66e-05	0.000671	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NCF1—atherosclerosis	2.65e-05	0.000668	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LCAT—atherosclerosis	2.62e-05	0.000661	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—FABP4—atherosclerosis	2.62e-05	0.000661	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NCF1—atherosclerosis	2.59e-05	0.000653	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—F2—atherosclerosis	2.58e-05	0.00065	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA4—atherosclerosis	2.57e-05	0.000649	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AGT—atherosclerosis	2.53e-05	0.000639	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP7A1—atherosclerosis	2.53e-05	0.000638	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—F2—atherosclerosis	2.52e-05	0.000636	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCR2—atherosclerosis	2.5e-05	0.000631	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDNRA—atherosclerosis	2.5e-05	0.000631	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CYBA—atherosclerosis	2.49e-05	0.000628	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AGT—atherosclerosis	2.48e-05	0.000625	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PIK3CG—atherosclerosis	2.46e-05	0.000622	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	2.44e-05	0.000617	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCR2—atherosclerosis	2.44e-05	0.000617	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLAT—atherosclerosis	2.44e-05	0.000615	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PARP1—atherosclerosis	2.44e-05	0.000615	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GHRL—atherosclerosis	2.44e-05	0.000615	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CYBA—atherosclerosis	2.43e-05	0.000614	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	2.41e-05	0.000608	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLAT—atherosclerosis	2.38e-05	0.000601	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PARP1—atherosclerosis	2.38e-05	0.000601	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GHRL—atherosclerosis	2.38e-05	0.000601	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—F2—atherosclerosis	2.34e-05	0.00059	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP27A1—atherosclerosis	2.34e-05	0.000589	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.31e-05	0.000582	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.31e-05	0.000582	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—F2—atherosclerosis	2.29e-05	0.000577	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PIK3CG—atherosclerosis	2.24e-05	0.000565	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	2.21e-05	0.000559	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA2—atherosclerosis	2.21e-05	0.000559	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALOX15—atherosclerosis	2.21e-05	0.000559	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	2.21e-05	0.000559	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	2.19e-05	0.000553	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCG5—atherosclerosis	2.19e-05	0.000552	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—KNG1—atherosclerosis	2.14e-05	0.000539	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AGTR1—atherosclerosis	2.12e-05	0.000536	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LPA—atherosclerosis	2.11e-05	0.000533	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—KNG1—atherosclerosis	2.09e-05	0.000528	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CCL2—atherosclerosis	2.08e-05	0.000526	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	2.08e-05	0.000525	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLG—atherosclerosis	2.07e-05	0.000523	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—BGN—atherosclerosis	2.05e-05	0.000516	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	2.04e-05	0.000515	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLG—atherosclerosis	2.03e-05	0.000511	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA5—atherosclerosis	2.03e-05	0.000511	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SOCS3—atherosclerosis	1.96e-05	0.000495	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.95e-05	0.000492	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	1.92e-05	0.000484	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP3—atherosclerosis	1.89e-05	0.000478	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF2—atherosclerosis	1.89e-05	0.000476	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.88e-05	0.000475	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP3—atherosclerosis	1.85e-05	0.000468	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF2—atherosclerosis	1.84e-05	0.000465	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOB—atherosclerosis	1.83e-05	0.000462	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.82e-05	0.00046	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—CXCL8—atherosclerosis	1.81e-05	0.000458	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—EDN1—atherosclerosis	1.8e-05	0.000455	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOB—atherosclerosis	1.79e-05	0.000452	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL5—atherosclerosis	1.79e-05	0.000451	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	1.78e-05	0.000448	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—EDN1—atherosclerosis	1.76e-05	0.000445	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL5—atherosclerosis	1.75e-05	0.000441	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LPL—atherosclerosis	1.75e-05	0.000441	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LCAT—atherosclerosis	1.71e-05	0.000432	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—FABP4—atherosclerosis	1.71e-05	0.000432	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LPL—atherosclerosis	1.71e-05	0.000431	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRKCG—atherosclerosis	1.7e-05	0.000429	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.69e-05	0.000426	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA4—atherosclerosis	1.68e-05	0.000424	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LIPC—atherosclerosis	1.68e-05	0.000423	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOC3—atherosclerosis	1.67e-05	0.000421	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	1.66e-05	0.00042	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LDLR—atherosclerosis	1.66e-05	0.000418	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SPP1—atherosclerosis	1.66e-05	0.000418	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.65e-05	0.000417	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—CXCL8—atherosclerosis	1.65e-05	0.000416	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SPP1—atherosclerosis	1.62e-05	0.000409	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CETP—atherosclerosis	1.62e-05	0.000409	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	1.61e-05	0.000407	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SCARB1—atherosclerosis	1.55e-05	0.000391	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PDGFB—atherosclerosis	1.53e-05	0.000387	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.53e-05	0.000385	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	1.5e-05	0.000378	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AGT—atherosclerosis	1.5e-05	0.000377	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOE—atherosclerosis	1.47e-05	0.00037	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LEP—atherosclerosis	1.47e-05	0.00037	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMGCR—atherosclerosis	1.46e-05	0.000369	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AGT—atherosclerosis	1.46e-05	0.000369	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CAV1—atherosclerosis	1.45e-05	0.000366	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—APOA1—atherosclerosis	1.45e-05	0.000365	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.45e-05	0.000365	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.45e-05	0.000365	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.45e-05	0.000365	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA2—atherosclerosis	1.45e-05	0.000365	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LEP—atherosclerosis	1.43e-05	0.000362	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOE—atherosclerosis	1.43e-05	0.000362	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.43e-05	0.000361	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CAV1—atherosclerosis	1.42e-05	0.000358	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—APOA1—atherosclerosis	1.42e-05	0.000358	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ESR1—atherosclerosis	1.4e-05	0.000353	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—F2—atherosclerosis	1.38e-05	0.000349	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LPA—atherosclerosis	1.38e-05	0.000349	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ESR1—atherosclerosis	1.37e-05	0.000345	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—F2—atherosclerosis	1.35e-05	0.000341	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—BGN—atherosclerosis	1.34e-05	0.000338	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA5—atherosclerosis	1.32e-05	0.000334	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PIK3CG—atherosclerosis	1.32e-05	0.000334	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ABCA1—atherosclerosis	1.3e-05	0.000329	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	1.29e-05	0.000326	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.27e-05	0.000322	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MAPK3—atherosclerosis	1.27e-05	0.00032	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INS—atherosclerosis	1.25e-05	0.000316	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	1.24e-05	0.000313	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CCL2—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.23e-05	0.000311	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INS—atherosclerosis	1.22e-05	0.000309	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1—atherosclerosis	1.21e-05	0.000306	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CCL2—atherosclerosis	1.2e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1—atherosclerosis	1.18e-05	0.000299	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SERPINE1—atherosclerosis	1.15e-05	0.00029	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	1.12e-05	0.000284	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMOX1—atherosclerosis	1.12e-05	0.000283	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.1e-05	0.000279	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NOS3—atherosclerosis	1.1e-05	0.000277	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LIPC—atherosclerosis	1.1e-05	0.000277	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000275	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LDLR—atherosclerosis	1.08e-05	0.000273	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NOS3—atherosclerosis	1.07e-05	0.000271	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOB—atherosclerosis	1.07e-05	0.000271	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CETP—atherosclerosis	1.06e-05	0.000267	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GSTM1—atherosclerosis	1.04e-05	0.000263	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LPL—atherosclerosis	1.02e-05	0.000258	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.01e-05	0.000256	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GPX1—atherosclerosis	9.99e-06	0.000252	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—CXCL8—atherosclerosis	9.74e-06	0.000246	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CD36—atherosclerosis	9.73e-06	0.000246	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMGCR—atherosclerosis	9.57e-06	0.000242	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	9.52e-06	0.00024	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT1—atherosclerosis	9.4e-06	0.000237	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—atherosclerosis	9.26e-06	0.000234	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—atherosclerosis	9.22e-06	0.000233	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	9.2e-06	0.000232	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—atherosclerosis	9.06e-06	0.000229	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARA—atherosclerosis	9.04e-06	0.000228	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MMP9—atherosclerosis	8.81e-06	0.000222	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AGT—atherosclerosis	8.76e-06	0.000221	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NFKB1—atherosclerosis	8.71e-06	0.00022	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MMP9—atherosclerosis	8.61e-06	0.000217	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOE—atherosclerosis	8.58e-06	0.000217	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK8—atherosclerosis	8.56e-06	0.000216	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT1—atherosclerosis	8.54e-06	0.000216	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ABCA1—atherosclerosis	8.53e-06	0.000215	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	8.52e-06	0.000215	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CAV1—atherosclerosis	8.5e-06	0.000215	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—APOA1—atherosclerosis	8.48e-06	0.000214	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	8.38e-06	0.000211	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	8.35e-06	0.000211	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—atherosclerosis	7.91e-06	0.0002	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—STAT3—atherosclerosis	7.83e-06	0.000198	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PIK3CG—atherosclerosis	7.75e-06	0.000195	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	7.74e-06	0.000195	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—STAT3—atherosclerosis	7.66e-06	0.000193	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MAPK3—atherosclerosis	7.48e-06	0.000189	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARG—atherosclerosis	7.48e-06	0.000189	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—INS—atherosclerosis	7.33e-06	0.000185	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.32e-06	0.000185	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	7.32e-06	0.000185	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TGFB1—atherosclerosis	7.26e-06	0.000183	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	7.1e-06	0.000179	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOB—atherosclerosis	7.01e-06	0.000177	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GSTM1—atherosclerosis	6.82e-06	0.000172	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ALB—atherosclerosis	6.72e-06	0.00017	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LPL—atherosclerosis	6.69e-06	0.000169	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GPX1—atherosclerosis	6.53e-06	0.000165	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NOS3—atherosclerosis	6.43e-06	0.000162	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CD36—atherosclerosis	6.36e-06	0.000161	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.03e-06	0.000152	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARA—atherosclerosis	5.91e-06	0.000149	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PTGS2—atherosclerosis	5.88e-06	0.000148	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AGT—atherosclerosis	5.73e-06	0.000145	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOE—atherosclerosis	5.61e-06	0.000142	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CAV1—atherosclerosis	5.56e-06	0.00014	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—APOA1—atherosclerosis	5.55e-06	0.00014	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—atherosclerosis	5.47e-06	0.000138	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—atherosclerosis	5.35e-06	0.000135	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.06e-06	0.000128	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT1—atherosclerosis	5.05e-06	0.000127	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT1—atherosclerosis	4.94e-06	0.000125	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARG—atherosclerosis	4.89e-06	0.000123	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—INS—atherosclerosis	4.79e-06	0.000121	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ALB—atherosclerosis	4.4e-06	0.000111	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NOS3—atherosclerosis	4.2e-06	0.000106	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PTGS2—atherosclerosis	3.85e-06	9.7e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKT1—atherosclerosis	2.96e-06	7.46e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKT1—atherosclerosis	1.93e-06	4.88e-05	CbGpPWpGaD
